US Pharma MarketingElevance talks
Elevance is pouring $1B into AI, but its digital chief says the goal is practical—better tools and an empathetic experience, not flashy new use cases. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene…
In the spirit of keeping up with how health insurers are using AI, I chatted with Elevance Health’s Ratnakar Lavu this week.
The chief digital information officer has held roles at Kohl’s, Nike and Macy’s ...
Source: Endpoints News